Cardiac drug safety a bench to bedside approach

Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk...

Full description

Saved in:
Bibliographic Details
Main Author: Killeen, Matthew J. (Author)
Format: Book
Language:English
Published: New Jersey World Scientific Publishing 2012
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Challenges facing the pharmaceutical industry in the 21st century
  • The cellular basis of cardiac electrophysiology
  • Clinical arrhythmia syndromes
  • The mechanisms underlying cardiac arrhythmias
  • The mechanisms underlying drug-induced arrhythmias
  • Assessing cardiac safety in drug development
  • Pediatric cardiac safety
  • Drug-induced atrial fibrillation
  • Navigating the future path of cardiac drug safety.